|
⚲
|
| Keyboard |
| Anne Vanlent | |
|---|---|
| Firm | |
| Address | 195 Church Street 14th Floor New Haven, CT 06510 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Trevi Therapeutics Inc | 021-442332 | Director | 55.0 M of 55.0 M |
||
| Trevi Therapeutics Inc | 021-418073 | Director | 3.0 M of 3.0 M |
||
| Trevi Therapeutics Inc | 021-417806 | Director | 11.8 M of 11.8 M |
||
| Onconova Therapeutics Inc | 021-249950 | Director | 1.5 M of 16.5 M |
||
| Ocera Therapeutics Inc | 021-206724 | Director | 28.0 M of 28.0 M |
||
| Ocera Therapeutics Inc | 021-200184 | Director | |||
| Ocera Therapeutics Inc | 021-199732 | Director | |||
| Ocera Therapeutics Inc | 021-199755 | Director | 20.0 M | ||
| Related People Network |
|---|
| Network #419 at Onconova Therapeutics Inc — files alongside 10 co-filers |